Avalo Therapeutics Inc.

AVTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$16.55

+$0.38 (+2.35%)

Sep 22, 2026, 2:21 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-78.26M	-35.13M	-31.54M	-41.66M	-84.38M	-63.5M
Depreciation & Amortization	344K	169K	158K	166K	1.66M	1.84M
Stock-Based Compensation	13.62M	5.85M	3.48M	7.55M	8.17M	6.79M
Other Working Capital	3.99M	-4.07M	-8.61M	-2.47M	961K	-1.77M
Other Non-Cash Items	8.83M	-15.35M	6.46M	7.22M	794K	18.57M
Deferred Income Tax	165K	114K	14K	28K	22K	197K
Change in Working Capital	3.84M	-4.71M	-9.24M	-60K	2.84M	-4.44M
Operating Cash Flow	-51.46M	-49.06M	-30.68M	-26.75M	-70.89M	-40.54M
Capital Expenditures	n/a	n/a	-158K	-95K	-113K	-63K
Cash Acquisitions	n/a	356K	n/a	n/a	n/a	11.2M
Purchase of Investments	-113.72M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	31.31M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	690K	n/a	25K	n/a	n/a	n/a
Investing Cash Flow	-81.72M	356K	-133K	-95K	-113K	11.13M
Debt Repayment	n/a	n/a	-21.24M	-14.81M	32.9M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-510K	60.22M	67K	n/a	1.93M	332K
Financial Cash Flow	14.59M	175.85M	25.04M	-14.7M	106.76M	44.78M
Net Cash Flow	-118.59M	127.15M	-5.77M	-41.45M	35.76M	15.38M
Free Cash Flow	-51.46M	-49.06M	-30.84M	-26.85M	-71.01M	-40.6M
Adj. Free Cash Flow	-65.08M	-54.91M	-34.32M	-34.4M	-79.18M	-47.39M
Maintenance CapEx	n/a	n/a	-158K	n/a	-113K	-63K
Growth CapEx	n/a	n/a	n/a	-95K	n/a	n/a
Owner Earnings	-51.46M	-49.06M	-30.84M	-26.75M	-71.01M	-40.6M